Relative to glutathione availability, one of the most important considerations has been to properly maintain the availability of cysteine in the blood as that is known to be the rate-limiting substrate for glutathione resynthesis[3]
NMAs are subject to inherent limitations, including assumptions of transitivity and consistency, which are not always met due to heterogeneity across trials
Cancer cells metabolize glucose through the glycolysis pathway in the presence of oxygen, while glutamine is converted into -KG and enters the tricarboxylic acid cycle
Synergistic Antioxidant Defense: Blend of ingredients like Silymarin, Glutathione, and Vitamin B6 synergistically reduce oxidative stress and support liver detox pathways
Folic acid is the most oxidized folate form
Novel pharmacological targets The neurokinin-1 receptor antagonist tradipitant was reported to improve nausea in gastroparesis, but the study was underpowered to show a benefit in the subgroup with diabetes [77]